Navigation Links
Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Monday, August 3, 2009
Date:7/29/2009

ncluding Merck & Co., Inc., and Ortho-McNeil-Janssen Pharmaceuticals, Inc.

Arena Pharmaceuticals(R) and Arena(R) are registered service marks of the company. "APD" is an abbreviation for Arena Pharmaceuticals Development.

Forward-Looking Statements

Certain statements in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements include statements about Arena's strategy, internal and partnered programs, and ability to develop compounds and commercialize drugs. For such statements, Arena claims the protection of the Private Securities Litigation Reform Act of 1995. Actual events or results may differ materially from Arena's expectations. Factors that could cause actual results to differ materially from the forward-looking statements include, but are not limited to, the timing, success and cost of Arena's lorcaserin program and other of its research and development programs; results of clinical trials or preclinical studies may not be predictive of future results; clinical trials and studies may not proceed at the time or in the manner Arena expects or at all; Arena's ability to partner lorcaserin or other of its compounds or programs; the timing and ability of Arena to receive regulatory approval for its drug candidates; Arena's ability to obtain additional funds; Arena's ability to obtain and defend its patents; and the timing and receipt of payments and fees, if any, from Arena's collaborators. Additional factors that could cause actual results to differ materially from those stated or implied by Arena's forward-looking statements are disclosed in Arena's filings with the Securities and Exchange Commission. These forward-looking statements represent Arena's judgment as of the time of this release. Arena disclaims any intent or obligation to update these forward-looking statements, other than as may be required under applicable
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. AHIMA Enters Multinational Arena to Support HIM Worldwide Advancement
2. Arena Pharmaceuticals Announces Pricing of Public Offering of Common Stock
3. Arena Pharmaceuticals Announces Public Offering of Common Stock
4. Cinergy Health Commentary On President Obamas Call for Cost Control, Competition in Health Insurance Arena
5. Arena Pharmaceuticals to Present at the Piper Jaffray Fourth Annual Europe Conference
6. Arena Pharmaceuticals to Receive $100 Million from Deerfield Management
7. New arenavirus discovered as cause of hemorrhagic fever outbreak in South Africa and Zambia
8. Arena Pharmaceuticals to Present at the 34th Annual Deutsche Bank Health Care Conference
9. Arena Pharmaceuticals Announces Positive Lorcaserin Pivotal Phase 3 Obesity Trial Results: Meets All Primary Efficacy and Safety Endpoints
10. Arena Pharmaceuticals to Report Fourth Quarter and Full Year 2008 Financial Results and to Host Conference Call and Webcast on Thursday, March 12, 2009
11. Arena Pharmaceuticals Announces Initiation by Merck of Phase 2 Clinical Trial of Niacin Receptor Agonist
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... HealthDay Reporter , TUESDAY, Oct. 21, 2014 ... cases in Dallas. But, mental health specialists say overblown fear ... Barack Obama on Friday appointed an Ebola "czar" to oversee ... Dallas nurses who cared for a Liberian man who died ... But the U.S. cases are miniscule in the context of ...
(Date:10/22/2014)... With the Affordable Care Act (ACA) open ... American Institutes for Research (AIR) finds that three out of ... insurance, but 42 percent say they are not likely or ... up for coverage. , The AIR survey found wide gaps ... to calculate correctly how much they owe for a routine ...
(Date:10/22/2014)... there are only 24 hours in a day, that doesn’t seem ... time within their busy schedules for exercise and fitness. Fortunately, one ... get in shape. Here are five ways you can reach your ... Up Your Commute , Consider riding a bike or taking the ... daily routine. If you must use your car to get to ...
(Date:10/22/2014)... HealthDay Reporter , TUESDAY, Oct. 21, 2014 ... are only about half as likely as white women to ... indicates, and the racial disparity persists even when donor eggs ... white patients became pregnant after IVF, compared to about 17 ... cycles over two years to tease out the impact of ...
(Date:10/22/2014)... By Dennis Thompson ... -- U.S. health officials on Monday officially tightened guidelines for ... with no skin exposure and use of a respirator at ... Prevention decided to issue the tougher rules after two Dallas ... diagnosed in the United States, Liberian national Thomas Eric Duncan. ...
Breaking Medicine News(10 mins):Health News:Ebola Anxiety: A Bigger Threat Now Than the Virus Itself 2Health News:Ebola Anxiety: A Bigger Threat Now Than the Virus Itself 3Health News:Many Americans Fail to Ask Basic Questions Before Signing Up for Health Insurance, National Survey Finds 2Health News:Many Americans Fail to Ask Basic Questions Before Signing Up for Health Insurance, National Survey Finds 3Health News:Many Americans Fail to Ask Basic Questions Before Signing Up for Health Insurance, National Survey Finds 4Health News:HealthGuideMD Presents Ways to Improve Your Exercise and Fitness 2Health News:Black Women Fare Worse With Fertility Treatments, Study Says 2Health News:Black Women Fare Worse With Fertility Treatments, Study Says 3Health News:CDC Tightens Rules on Caring for Ebola Patients 2Health News:CDC Tightens Rules on Caring for Ebola Patients 3
... Focused Fitness, SAN DIEGO, Jan. 3 ... annual survey of its extensive worldwide network of,personal ... and lifestyle and weight management consultants to identify ... to be filled with,water aerobics, boxing clubs and ...
... Education at Make-or-Break Juncture, Must Be ... Prioritized Despite State,s Budget Crunch, OAKLAND, Calif., Jan. 3 ... well-being of California,s children and the,state for years to come. ... study by,Children Now, a leading nonpartisan, nonprofit organization dedicated to,giving ...
... Jan. 2 Insulet Corporation,(Nasdaq: PODD ), ... System, today announced that Duane DeSisto, Chief Executive,Officer, ... Mr. DeSisto is scheduled to present an overview ... Tuesday, January 8, 2008 at The Westin St.,Francis ...
... GPRO ) announced today that the Company will ... January 9, 2008 at,approximately 3:30 p.m. Pacific Time (6:30 ... live and may be accessed through a,link on the ... The webcast will be available for 30 days,following the ...
... Girlfriend Spoke Regarding Her Rape Accusation, LOS ANGELES, ... of Elizabeth Mazzocchi regarding her lawsuit against,Esai Morales:, ... you all for coming out today. I. Background, ... CEO of a company called,Critical Mass Entertainment Group. Critical ...
... often waited hours after calling emergency hotlines , , WEDNESDAY, ... a potentially dangerous infectious disease outbreak may find themselves ... hour or more, a new phone survey finds. ... picks up -- researchers could not get through on ...
Cached Medicine News:Health News:American Council On Exercise (ACE) 2008 Fitness Trend Predictions 2Health News:American Council On Exercise (ACE) 2008 Fitness Trend Predictions 3Health News:American Council On Exercise (ACE) 2008 Fitness Trend Predictions 4Health News:The Future of California's Kids on the Line in 2008, According to New Children Now Report Card, 'The State of the State's Children' 2Health News:Gen-Probe to Webcast Presentation at 26th Annual JPMorgan Healthcare Conference 2Health News:Transcript of Elizabeth Mazzocchi Press Conference 2Health News:Transcript of Elizabeth Mazzocchi Press Conference 3Health News:Transcript of Elizabeth Mazzocchi Press Conference 4Health News:Transcript of Elizabeth Mazzocchi Press Conference 5Health News:Health Departments Slow to Respond to Disease Outbreaks 2
(Date:10/22/2014)... SANTA CLARA, Calif. , Oct. 22, 2014 /PRNewswire/ ... today announced the introduction of the cQUB™-1 (cQuest Ultrasound ... cQUB white-label ultrasound systems designed and manufactured by Cephasonics ... brand name and model number. Cephasonics will be showcasing ... 2014 being held this week in Chongqing, ...
(Date:10/22/2014)... Antigen Discovery Inc. (ADi), a privately held ... the receipt of a National Institutes of Health (NIH) ... Institute of Dental and Craniofacial Research (NIDCR). The one-year ... Protein Microarray Chip, which will contain every protein in ... in the development of safe and effective vaccines and ...
(Date:10/22/2014)... Calif. , Oct. 22, 2014  Paper ... products, has developed APLS ® Body Guard ... minimizes the spread of bacteria and virus while ... APLS Body Guard Bio features a rugged, external ... edges that create a leak-proof inner chamber that ...
Breaking Medicine Technology:Cephasonics Launches the cQUB-1, First Product in New Family of cQUB White-Label Ultrasound Systems Targeted at Medical Applications 2Cephasonics Launches the cQUB-1, First Product in New Family of cQUB White-Label Ultrasound Systems Targeted at Medical Applications 3Biomarker Discovery Company, Antigen Discovery Inc., Awarded an NIH Phase I Small Business Innovation Research Grant to Develop a Pan-HIV Protein Microarray Chip 2New, State-Of-The-Art Body Bag Minimizes The Spread Of Bacteria And Virus 2
... Canopus BioPharma, Inc.,(OTC: CBIA), is pleased to ... granted approval for a Phase II study in ... on the,gastrointestional tract from radiation-induced mucositis. This new ... of CB1400 as a novel,preventative, anti-mucositis agent., ...
... generally consistent with oral olanzapine ... the exception of injection-related events, VENICE, Italy, June ... showed that the,efficacy and safety profile of olanzapine LAI ... exception of injection-related,events. Results from a 24-week maintenance study ...
Cached Medicine Technology:CB1400, Patented by Canopus BioPharma, Enters Phase II Clinical Trials for the Prevention of Mucositis in Patients With Cancer of the Head and Neck 2Olanzapine Long-Acting Injection (LAI) Data Presented at First Annual Schizophrenia International Research Society Conference 2Olanzapine Long-Acting Injection (LAI) Data Presented at First Annual Schizophrenia International Research Society Conference 3Olanzapine Long-Acting Injection (LAI) Data Presented at First Annual Schizophrenia International Research Society Conference 4Olanzapine Long-Acting Injection (LAI) Data Presented at First Annual Schizophrenia International Research Society Conference 5Olanzapine Long-Acting Injection (LAI) Data Presented at First Annual Schizophrenia International Research Society Conference 6Olanzapine Long-Acting Injection (LAI) Data Presented at First Annual Schizophrenia International Research Society Conference 7Olanzapine Long-Acting Injection (LAI) Data Presented at First Annual Schizophrenia International Research Society Conference 8
Immuno-turbidimetric Assay of D-Dimer by STA© Analyzers. Microlatex particles coated with two different mouse monoclonal anti-human D-Dimer antibodies....
Detection of Lupus Anticoagulants. Freeze-dried hexagonal phase phos-phatidylethanolamine; normal plasma with heparin inhibitor; PTT-LS reagent of cephalin and particulate siliceous activator;all fre...
... Assay of Protein C Activity ... plasma free of Protein C; ... c. contortrix venom for specific ... with an activator selected specially ...
Immuno-turbidimetric Assay for Protein S Antigen. Suspension of microlatex particles coated with specific antibodies....
Medicine Products: